Essais liés5clinical trials
VilleSochaczewlocalisation
PaysPolandlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06937229

Ouvrir le site du centre

Essais cliniques associés

5
MoléculeIndication / populationPhaseNCTTitreStatut
KarXT Alzheimer Phase 3 NCT06937229 A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) RECRUITING
Xanomeline/Trospium Chloride Capsule Alzheimer Phase 3 NCT07011745 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease RECRUITING
KarXT Alzheimer Phase 3 NCT06585787 A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4) RECRUITING
EXV-802 Alzheimer Phase 2/3 NCT07284472 SERENADA — Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia RECRUITING
Lu AG09222 Migraine Phase 2 NCT06323928 PROCEED — A Dose-finding Trial With Lu-AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments COMPLETED